Handelsavisen
prelaunch
Companies Healthcare GFCM.BK
GF
GFCM.BK SET (Bangkok) Healthcare Facilities & Services

Gfcm.Bk

Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
4,64 %
Op margin
9,8 %
ROE
4,0 %
Net margin
6,3 %
Debt / equity
0,05
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

GFCM.BK operates in the healthcare facilities and services industry, providing biotechnology-related services and equipment, primarily generating revenue through service provision and product sales.

Business. GFCM.BK operates in the healthcare facilities and services industry, providing biotechnology-related services and equipment, primarily generating revenue through service provision and product sales.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityBiotechnology
Generated · model-assisted
Sell-side consensus
HOLD2 analysts
0 buy1 hold1 sell
Avg 12m price target3,50

Analyst recommendations

2 analysts · consensus Hold
Buy0
Hold1
Sell1
12-month price target
3,50
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Hold
2 analysts · indicative
Ownership
not yet wired
Profitability
4,0 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning GFCM.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to GFCM.BK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    GFCM.BK operates in the healthcare facilities and services industry, providing biotechnology-related services and equipment, primarily generating revenue through service provision and product sales.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityBiotechnology
    AI synthesis
    GENERATED

    GFCM.BK maintains a strong liquidity position, with a current ratio of 2.77, indicating the company can cover its short-term liabilities more than two and a half times over with its current assets. The company's cash and equivalents amount to 130.75 million THB, which is a significant portion of its total assets, suggesting a conservative approach to liquidity management. However, the company reported negative free cash flow of 4.30 million THB, which may indicate that capital expenditures are outpacing cash inflows from operations.

    In terms of profitability, GFCM.BK's return on equity (ROE) is 3.95%, and its return on assets (ROA) is 3.34%. These figures are below the industry median for ROE and ROA, suggesting that the company is not generating returns as efficiently as its peers. The company's operating income of 34.76 million THB and net income of 22.40 million THB reflect a relatively modest profit margin, which may be a concern for investors seeking higher returns.

    GFCM.BK's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no significant geographic diversification reported. This concentration may expose the company to higher risks if the segment or region experiences a downturn. The company's total revenue for the period was 352.99 million THB, with gross profit of 147.16 million THB, indicating a gross margin of approximately 41.7%.

    Looking at the company's growth trajectory, there is no specific outlook provided for the current or next fiscal year. However, the company's capital expenditures of 41.59 million THB suggest a commitment to maintaining or expanding its operational capacity. The absence of a clear growth strategy or significant investment in research and development may limit the company's ability to innovate and capture new market opportunities.

    The risk assessment for GFCM.BK indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company's debt-to-equity ratio is 0.05, which is relatively low, suggesting a conservative capital structure. However, the negative free cash flow and the absence of a strong growth strategy may pose long-term risks to the company's financial stability.

    Recent events, including analyst estimates, show a mean price target of 3.50 THB, with a median and high price target also at 3.50 THB. The lack of strong buy or buy recommendations, with only one hold recommendation, suggests a cautious outlook from analysts. This may reflect concerns about the company's growth potential and profitability.

    Key takeaways
    • GFCM.BK has a strong liquidity position with a current ratio of 2.77.
    • The company's ROE and ROA are below industry medians, indicating lower profitability.
    • Revenue is concentrated in a single segment, increasing exposure to market risks.
    • Analysts have a cautious outlook, with no strong buy recommendations.
    • The company's capital expenditures suggest a focus on maintaining operational capacity.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $567.7M
    Net cash
    $100.7M
    Current ratio
    2.8
    Debt / equity
    0.1
    ROA
    3.3%
    ROE
    4.0%
    Cash conversion
    285.0%
    CapEx / revenue
    -11.8%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$3,50
    Mean$3,50
    Median$3,50
    High$3,50
    Spot
    12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin9,8 %Above median
    Net Margin6,3 %Above median
    ROE4,0 %Below median
    Capex / Rev-11,8 %Below median
    D/E0,05Above P75
    Cash Conv2,85Above P75

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • GFCM.BK Market data — financials · 2026-05-28
    • Genesis Fertility Center PCL Market data — analyst estimates · 2026-05-28

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    GFCM.BKCanonical
    SET (Bangkok) · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage